Introduction
============

Aqueous humor, a product of the ciliary process, occupies the anterior and posterior chambers of the eye. It supplies nutrients to the nonvascularized cornea, lens, and trabecular meshwork. It is drained through two major pathways, the iridocorneal and the uveoscleral outflows I mean the constitution of aqueous humor affects the functioning of cells, and also the functioning of cells affects the aqueous composition. In addition, functional barriers between the anterior and posterior segments are not strict. The composition of the aqueous is also likely to be affected by the physiology/pathophysiology of the retina. Consequently, several growth factors have been detected in the aqueous humor, and the composition of these proteins changes dramatically in different ocular conditions, especially in inflammation and glaucoma \[[@r1],[@r2]\].

Evaluation of the aqueous composition can be a powerful tool in understanding the pathophysiology and treatment response to many ocular conditions. Assessment of cytokines in uveitis patients revealed the presence of Interleukin (IL)-2, 6, 10, 12, Interferon (IFN)-γ, tumor growth factor (TGF)-β2, tumor necrosis factor (TNF)-α, and macrophage migration inhibitory factor. One major limitation of testing the aqueous is that only small sample volumes can be obtained from human eyes. Typically 50-150 µl of aqueous can be obtained from one human eyes, which is barely sufficient to test a few cytokines using traditional ELISA techniques including sequential ELISA. Alternatively, the samples can be pooled, but this can mask individual patient differences. However, with the introduction of flow cytometric bead-based technology, multiple cytokine analytes can now be quantified simultaneously and rapidly in individual samples. This technique has better reproducibility and sensitivity than the traditional ELISA \[[@r3]\]. The cytometric bead array (CBA) system has proven effective in testing samples from cell culture supernatant, human serum, tears, and nasal lavage \[[@r4]\]. In this pilot study, we investigated the detectability of an array of proteins in the aqueous humor obtained from normal eyes to determine if this analysis could be useful in understanding disease processes and treatment responses within the eye.

The aim of this study was to investigate whether large numbers of analytes can be identified in clinically available aqueous samples. Large numbers of analytes are needed to perform global analysis for identifying maps, networks, pathways, and disease processes. Such an analysis would be useful to compare ocular environment in different conditions. Another aim of this study was to document the detectability of certain biomarkers in the aqueous.

Methods
=======

Samples
-------

Aqueous samples were collected from eight non-diabetic and 2 diabetic patients undergoing cataract surgery. Aqueous humor (80--100 µl) was withdrawn through a limbal paracentesis site using a 27 gauge needle in a tuberculin syringe. Care was taken to avoid touching intraocular tissues and to prevent contamination of aqueous samples with blood. The samples were immediately frozen and stored at −80 °C. Patients with other ocular or systemic diseases such as inflammatory diseases were excluded from the study. Informed consent was obtained from the patients, and the research was in compliance with the tenets of the University of Florida and the Declaration of Helsinki for experiments involving human tissue.

Multiplex analysis
------------------

Multiplex analysis was performed at Rules-Based Medicine (Austin, TX), which uses Multi-Analyte Profiles (MAPs) based on powerful Luminex xMAP® technology to discover biomarker patterns within very small sample volumes. The aqueous samples were thawed at room temperature, vortexed, and then spun at 13,000x g for 5 min to remove any precipitates. Maximum available volume (80--100 µl) was removed and placed into a master microtiter plate for MAP antigen analysis. Using automated pipetting, an aliquot of each sample was introduced into one of the capture microsphere multiplexes of the human antigen MAP. The sample and capture microspheres were thoroughly mixed and incubated at room temperature for 1 h. Multiplexed cocktails of biotinylated reporter antibodies for each multiplex were then added robotically and thoroughly mixed. After this, the mixture was incubated for an additional hour at room temperature. Multiplexes were developed using an excess of streptavidin-phycoerythrin solution, which was thoroughly mixed into each multiplex and incubated for 1 h at room temperature. The volume of each multiplexed reaction was reduced by vacuum filtration, and the volume increased by dilution into a matrix buffer for analysis. Analysis was performed in a Luminex 100 instrument (Luminex, Austin, TX), and the resulting data stream was interpreted using proprietary data analysis software (developed at Rules-Based Medicine and licensed to Qiagen Instruments, Qiagen Inc., Valencia, CA). For each multiplex, calibrators and controls were both included on each microtiter plate. Eight-point calibrators were run in the first and last column of each plate, and three-level controls were included in duplicate. Testing results were first determined for the high, medium, and low controls of each multiplex to ensure proper assay performance. Unknown values for each of the analytes that localized in a specific multiplex were determined using weighted and non-weighted curve fitting algorithms included in the data analysis package.

Analysis
--------

The value for each analyte was obtained as a concentration (example; mg/ml). The values of eight samples (or less if an analyte could not be analyzed in all samples because of insufficient quantity of the sample) were averaged and compared to the sensitivity of the system. An analyte was considered "detectable" if the levels exceeded the minimal detectable levels.

The detectable analytes were further analyzed to identify biological/disease processes and the involved pathways/networks they participated in by using MetaCore™ analysis software (GeneGo Inc., St. Joseph, MI). The manually annotated database includes over 160,000 human protein interactions and metabolic reactions. The whole data set of 52 detectable analytes was imported in MetaCore to build an analysis of functional ontologies including GeneGo process, GeneGo disease process, canonical pathway maps, and networks. Calculation of statistical significance throughout MetaCore for maps, networks, and processes are based on p value, which are calculated based on hypergeometric distribution. P values essentially represent the probability of particular mapping arising by chance given the numbers of genes in the set of all genes on maps/networks/processes, genes on a particular map/network/process, and genes in the experiment \[[@r5]\]. We used a p value of 0.05 for the cutoff. The degree of relevance to different categories for the uploaded data sets is defined by p values, so that the lower p value obtains higher priority.

The experimental data were input to build networks. The three different scoring functions used to rank the small subnetworks created by the network building algorithms were zScore, gScore, and p value. The zScore ranks the subnetworks (within the analyzed network) with regards to their saturation with genes from the experiment. A high zScore means the network is highly saturated with genes from the experiment. In other words, it means that relatively larger number of genes/analytes in a particular network were present in the aqueous sample. Each network is comprised of canonical pathways. The gScore modifies the zScore based on the number of canonical pathways used to build the network. If a network has a high gScore, it is saturated with expressed genes (from the zScore), and it contains many canonical pathways.

Results
=======

General analysis
----------------

A total of 90 predetermined analytes were analyzed. All 90 analytes could be analyzed in at least one sample from normal patients. In normal samples, 57% (52 out of 90) of the analytes were detectable (above the sensitivity of the method), and 42% of analytes (38 out of 90) were undetectable either because their values were below the sensitivity of the method (28 out of 90; 31%) or their quantities were insufficient to assign a value (10 out of 90; 11%). A list of detectable proteins is provided in [Table 1](#t1){ref-type="table"}.

###### List of analytes detected in aqueous.

  **Number**   **Analyte**                         **SwissProt ID**   **Unit**   **Average**   **Standard deviation**   **Folds above detectable limits**
  ------------ ----------------------------------- ------------------ ---------- ------------- ------------------------ -----------------------------------
  1            Alpha-1 Antitrypsin                 P01009             mg/ml      0.00274       0.000893                 52033.62
  2            Adiponectin                         Q15848             μg/ml      0.01054       0.002623                 10.545
  3            Alpha-2 Macroglobulin               P01023             mg/ml      0.0006        0.000777                 2.07352
  4            Alpha-Fetoprotein                   P02771             ng/ml      0.33637       0.072147                 3.911337
  5            Apolipoprotein A1                   P02647             μg/ml      0.72          0.918                    22077.51
  6            Apolipoprotein CIII                 P02656             μg/ml      0.023         0.009896                 1733.333
  7            Apolipoprotein H                    P02749             μg/ml      0.61937       0.554624                 14076.7
  8            Beta-2 Microglobulin                P61769             μg/ml      0.18121       0.126304                 2745.644
  9            Complement 3                        P01024             mg/ml      0.00161       0.00162                  61454.37
  10           Cancer Antigen 125                  Q14596             U/ml       9.83          11.01929                 11.64692
  11           Cancer Antigen 19--9                Q9BXJ9             U/ml       0.11567       0.048019                 2.351045
  12           CD40                                P27512             ng/ml      0.03338       0.016927                 7.949405
  13           C Reactive Protein                  P02741             μg/ml      0.01163       0.011371                 1520.686
  14           Endothelin-1                        P05305             pg/ml      3.867         1.675357                 2.693245
  15           EN-RAGE                             P80511             ng/ml      0.050                                  10.06
  16           Eotaxin                             P51671             pg/ml      11.737        3.148795                 1.431402
  17           Erythropoietin                      P01588             pg/ml      47.02         54.47922                 1.416416
  18           Ferritin                            P02792             ng/ml      3.10333       0.5231                   443.3333
  19           FGF basic                           P09038             pg/ml      20.66         5.233832                 1.054082
  20           Fibrinogen                          P02671             mg/ml      0.00021       0.000133                 4374.364
  21           G-CSF                               P09919             pg/ml      1.26                                   1.26
  22           Glutathione S-Transferase           P09488             ng/ml      0.86112       0.971832                 10.65749
  23           Haptoglobin                         P00739             μg/ml      0.5           0.476                    415.6686
  24           IgA                                 P24071             μg/ml      0.97          0.85                     23278.44
  25           IGF-1                               P01343             ng/ml      3.7295        4.838829                 4.661875
  26           IgM                                 P20769             mg/ml      4.82e−5       2.21e−5                  638.4106
  27           IL-1ra                              P18510             pg/ml      5.81                                   1.936667
  28           IL-6                                P05231             pg/ml      5.81          7.328891                 2.381148
  29           IL-8                                P10145             pg/ml      4.9412        2.029345                 7.038818
  30           Leptin                              P41159             ng/ml      0.11360       0.178015                 5.514887
  31           Lipoprotein (a)                     P08519             μg/ml      0.0637        0.043628                 3.445946
  32           MCP-1                               P13500             pg/ml      308.87        191.7174                 29.69952
  33           MIP-1alpha                          P10147             pg/ml      7.1362        2.41117                  2.744712
  34           MIP-1beta                           P13236             pg/ml      21.707        13.95261                 2.863786
  35           MMP-3                               P08254             ng/ml      0.22912       0.227617                 5.728125
  36           Myoglobin                           P02144             ng/ml      0.924         0.331162                 176
  37           PAI-1                               P05121             ng/ml      0.62833       0.483399                 139.6296
  38           Prostatic Acid Phosphatase          P15309             ng/ml      0.01419       0.00844                  2.075815
  39           PAPP-A                              Q13219             U/ml       0.01645       0.011151                 2.223057
  40           "Prostate Specific Antigen, Free"   P07288             ng/ml      0.0051                                 1.094421
  41           RANTES                              P13501             ng/ml      0.00233       0.001534                 9.668737
  42           Serum Amyloid P                     P02743             μg/ml      0.0096        0.003076                 841.7391
  43           Stem Cell Factor                    P21583             pg/ml      20.575        4.99135                  1.85027
  44           SGOT                                P17174             μg/ml      1.0505        0.466578                 1.411962
  45           SHBG                                P04278             nmol/l     0.1696        0.070577                 652.3077
  46           Thyroxine Binding Globulin          P05543             μg/ml      0.29598       0.26957                  4339.993
  47           Tissue Factor                       P13726             ng/ml      0.4732        0.156952                 2.813615
  48           TIMP-1                              P01033             ng/ml      13.742        11.56826                 327.5924
  49           TNF RII                             Q92956             ng/ml      0.07006       0.051629                 107.7949
  50           Thyroid Stimulating Hormone         P01215             U/ml       0.0217        0.018148                 3.882143
  51           VCAM-1                              P19320             ng/ml      2.22          1.408971                 170.7692
  52           VEGF                                P15692             pg/ml      214.987       91.01978                 143.325

Out of 90 analytes evaluated, 52 were detectable in the aqueous samples. These included cytokines, growth factors, cell adhesion molecules immunoglobulin, components of immune system, and enzymes. VEGF is especially relevant for studying the pathobiology of various retinal disorders.

Functional analysis
-------------------

The detected analytes were evaluated by MetaCore software to identify possible relations among proteins. The accession numbers ([SwissProt](http://www.expasy.org/sprot/) IDs) for the analytes in [Table 1](#t1){ref-type="table"} were identified and uploaded into the MetaCore software. This software generates networks based on interactions between uploaded proteins and all others proteins/genes stored in the knowledge database. For each network, the probability of finding the uploaded proteins in the network by chance was calculated. The negative logarithm of the probability represents how relevant this network was to the list of uploaded proteins.

### Distribution by canonical pathways maps

Canonical pathway maps represent a set of approximately 500 signaling and metabolic maps covering human biology in a comprehensive way. Of the 52 proteins identified in the normal aqueous, 35 were present in the MetaCore database on maps. The 10 most significant canonical pathway maps that are represented relate to immune response, development, and cell adhesion ([Table 2](#t2){ref-type="table"}).

###### List of 10 most significant canonical pathways maps represented by detectable analytes in normal aqueous samples.

  **Number**   **Name**                                                               **p value**
  ------------ ---------------------------------------------------------------------- -------------
  1            Immune response \_Histamine signaling in dendritic cells               1.098e−7
  2            Development_Leptin signaling via JAK/STAT and MAPK cascades            1.194e−7
  3            Immune response \_Oncostatin M signaling via JAK-Stat in mouse cells   1.335e−6
  4            Immune response \_Oncostatin M signaling via JAK-Stat in human cells   2.099e−6
  5            Immune response \_Histamine H1 receptor signaling in immune response   2.881e−6
  6            Cell adhesion_ECM remodeling                                           3.911e−6
  7            Immune response \_MIF-mediated glucocorticoid regulation               1.501e−4
  8            Immune response \_IL1 signaling pathway                                5.128e−4
  9            Immune response \_Oncostatin M signaling via MAPK in mouse cells       6.111e−4
  10           Immune response \_Oncostatin M signaling via MAPK in human cells       7.207e−4

These pathways prominently represent immune and cell adhesion pathways.

### Most relevant networks

The list of detectable analytes was used to generate biological networks using the Analyze Networks (AN) algorithm, which is a variant of the shortest paths algorithm, with main parameters of (1) relative enrichment with the uploaded data and (2) relative saturation of networks with canonical pathways. Subnetworks are ranked by a p value and gScore and interpreted in terms of Gene Ontology. All 52 proteins identified were present in the MetaCore database on networks ([Table 3](#t3){ref-type="table"}).

###### List of 10 most statistically significant canonical pathways maps represented by detectable analytes in normal aqueous samples.

  **Number**   **Key network objects**                                       **GO Processes**                                                                                                                                                                                                                                                                          **p value**   **zScore**   **gScore**
  ------------ ------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------- ------------ ------------
  1            A2M, Kallikrein 3 (PSA), Alpha 1-antitrypsin, VEGF-A, PAI1    organ development (61.4%; 4.075e−10), response to wounding (36.4%; 4.455e−10), response to external stimulus (43.2%; 4.572e−10), cell proliferation (50.0%; 5.309e−10), positive regulation of cell proliferation (31.8%; 6.986e−10)                                                      2.36e−31      61.1         61.1
  2            Stromelysin-1, CCL2, TIMP1, MIP-1-beta, Alpha 1-antitrypsin   response to external stimulus (47.8%; 1.468e−12), response to wounding (37.0%; 9.322e−11), wound healing (23.9%; 1.290e−10), blood coagulation (15.2%; 3.146e−07), coagulation (15.2%; 3.914e−07)                                                                                         8.46e−29      57.4         57.4
  3            VEGF-A, Endothelin-1, PAI1, Stromelysin-1, CD40(TNFRSF5)      response to stimulus (75.5%; 5.440e−14), response to stress (55.1%; 3.472e−13), protein kinase cascade (40.8%; 3.739e−13), response to external stimulus (46.9%; 7.466e−13), cell surface receptor linked signal transduction (57.1%; 1.494e−12)                                          1.14e−28      56.8         56.8
  4            F3, Beta-2-glycoprotein I (APOH), VCAM1, MIP-1-beta, CCL2     cell adhesion (53.2%; 8.293e−19), biological adhesion (53.2%; 8.293e−19), response to wounding (51.1%; 1.218e−18), localization of cell (51.1%; 5.939e−17), cell motility (51.1%; 5.939e−17)                                                                                              1.14e−28      56.8         58.1
  5            CD40(TNFRSF5), CRP, G-CSF, F3, APCS                           immune system process (57.1%; 2.349e−16), immune response (44.9%; 1.384e−14), response to stimulus (73.5%; 4.961e−13), defense response (40.8%; 6.493e−12), adaptive immune response (20.4%; 1.681e−10)                                                                                   1.14e−28      56.8         56.8
  6            APOA1, PPAP, Adiponectin, APOC3, MIP-1-alpha                  sterol transport (15.2%; 3.842e−08), cholesterol transport (15.2%; 3.842e−08), triacylglycerol metabolic process (12.1%; 1.119e−06), lipid transport (15.2%; 1.661e−06), response to stimulus (63.6%; 1.781e−06)                                                                          4.46e−27      57.2         57.2
  7            CCL2, CCL5, Eotaxin, MIP-1-beta, MIP-1-alpha                  cytokine and chemokine mediated signaling pathway (25.5%; 4.692e−17), locomotory behavior (38.3%; 1.594e−16), chemotaxis (31.9%; 5.793e−16), taxis (31.9%; 5.793e−16), response to external stimulus (53.2%; 1.704e−15)                                                                   1.82e−23      48           68
  8            A2M, Endothelin-1, CCL5, IL-6, MIP-1-beta                     response to stimulus (75.5%; 5.440e−14), response to external stimulus (49.0%; 7.073e−14), regulation of protein metabolic process (34.7%; 5.809e−13), defense response (42.9%; 6.006e−13), inflammatory response (34.7%; 1.171e−12)                                                      5.95e−21      43.6         43.6
  9            Beta-2-microglobulin, APOA1, TR2(TNFRSF14), VCAM1, GSTM1      response to stimulus (75.0%; 1.873e−11), positive regulation of transferase activity (27.5%; 2.304e−10), positive regulation of kinase activity (25.0%; 3.531e−09), positive regulation of catalytic activity (27.5%; 2.827e−08), regulation of transferase activity (27.5%; 3.249e−08)   4.09e−16      34.9         34.9
  10           PPAP, Thyroxine-binding globulin, Adiponectin, Epo, APOLPA    protein kinase cascade (34.3%; 2.065e−07), intracellular signaling cascade (48.6%; 2.204e−07), positive regulation of kinase activity (22.9%; 2.930e−07), positive regulation of transferase activity (22.9%; 3.458e−07), regulation of cell differentiation (25.7%; 3.570e−07)           2.29e−14      33.3         33.3

Network objects represent the fraction of the number of genes from input list against total number of genes from MetaCore database for respective network. These included cell adhesion pathways, cytokine signaling pathways, and pathways for immune system processes.

### Distribution by GeneGo and Gene Ontology processes

The content of about 110 cellular and molecular processes is defined and annotated by GeneGo. Each process represents a preset network of protein interactions characteristic to the process. Of the 52 proteins identified, 41 were present in the MetaCore database on GeneGo processes. The top 10 processes represented in the normal aqueous samples are given in [Table 4](#t4){ref-type="table"}. These processes mostly represented responses to stimuli, immune processes, response to wounding, inflammation, defense and stress, cell proliferation, and chemotaxis.

###### List of 10 most statistically significant GeneGO processes represented by detectable analytes in normal aqueous samples.

  **Number**   **Process**                                 **p value**
  ------------ ------------------------------------------- -------------
  1            Response to external stimulus               1.63e−11
  2            Response to stimulus                        2.9e−11
  3            Immune system process                       2.41e−9
  4            Response to wounding                        1.02e−8
  5            Inflammatory response                       1.04e−7
  6            Defense response                            1.36e−7
  7            Immune response                             3.86e−7
  8            Response to stress                          6.83e−7
  9            Positive regulation of cell proliferation   7.37e−6
  10           Chemotaxis                                  1.47e−5

Some of these processes, such as response to stress, chemotaxis, regulation of cell proliferation, wound healing, and immune system processes are relevant in ocular diseases.

### Distribution by disease biomarkers

There are over 500 human diseases with gene content annotated by GeneGo and organized in disease folders, which are further organized into a hierarchical tree. Certain factors may affect p value prioritization for diseases. For example, the gene content may vary greatly between complex diseases (such as cancers and some Mendelian diseases), and also, the coverage of different diseases in the literature may be skewed. Of the 52 proteins identified, 50 were present in the MetaCore database on diseases. The diseases whose biomarkers were detectable in the aqueous are relevant conditions of the retina including vascular (together with vascular occlusive and cardiovascular diseases), arteriosclerosis, ischemia, necrosis, and inflammation. A list of top 10 disease processes represented is given in [Table 5](#t5){ref-type="table"}.

###### List of 10 most statistically significant disease biomarkers represented by detectable analytes in normal aqueous samples.

  **Number**   **Name**                      **p value**
  ------------ ----------------------------- -------------
  1            Vascular Diseases             1.843e−21
  2            Arterial Occlusive Diseases   5.575e−21
  3            Cardiovascular Diseases       4.352e−20
  4            Arteriosclerosis              5.866e−20
  5            Necrosis                      1.571e−18
  6            Ischemia                      9.303e−18
  7            Myocardial Ischemia           1.746e−16
  8            Coronary Disease              1.269e−15
  9            Infection                     1.637e−15
  10           Lung Diseases, Obstructive    2.774e−15

Biomarkers for vascular diseases, ischemia, necrosis, and infection are highly relevant for ocular pathology.

Comparison between non-diabetic and diabetic aqueous samples
------------------------------------------------------------

To provide the proof of principle that functional analysis of the aqueous using multiplex technology could provide useful information and identify differences between normal and disease conditions, we also performed the analysis on two diabetic samples. Out of 90 analytes, 44 (49%) were detected and 33 were not detected (36%). Quantity was not sufficient to analyze 13 analytes.

The comparison identified significant differences between the two groups with several analytes showing upregulation and downregulation. Analytes that showed twofold or more changes are shown in [Figure 1](#f1){ref-type="fig"}. There were analytes uniquely expressed in diabetic or normal samples. Comparison between processes in non-diabetic and diabetic aqueous are shown in [Table 6](#t6){ref-type="table"}. There were also changes in the canonical pathways ([Figure 2](#f2){ref-type="fig"}). The top 10 most significantly altered GeneGo processes included the ones that involved cell adhesion (platelet-endothelium leukocyte interactions, inflammation, chemotaxis, proliferation \[positive regulation\], and signal transduction; [Figure 3](#f3){ref-type="fig"}). The vascular diseases, infarction, arterial occlusion, ischemia, arteriosclerosis, and necrosis were the most significant diseases whose biomarkers were perturbed in diabetes ([Figure 4](#f4){ref-type="fig"}).

![List of analytes that showed a twofold or more change in their levels in diabetic aqueous samples when compared to non-diabetic samples. The figure shows analytes that showed significant difference (2 fold or more; abscissa) between normal and the diabetic aqueous. The most prominent decrease was observed in glutathione S-transferase, and an increase in fibrinogen.](mv-v15-60-f1){#f1}

###### Comparison between processes in diabetic and non-diabetic aqueous humor.

  **Number**                        **Processes**                                                                                                                                                 **Size**   **Target**   **Pathways**   **p value**   **zScore**
  --------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------- ------------ -------------- ------------- ------------
  **Common**                                                                                                                                                                                                                                           
  1                                 Locomotory behavior (42.6%), G-protein coupled receptor protein signaling pathway (51.1%), cell surface receptor linked signal transduction (66.0%)           50         13           10             8.58e−29      57.35
  2                                 Response to external stimulus (56.2%), response to wounding (47.9%), response to stimulus (79.2%)                                                             50         14           1              1.73e−31      61.78
  3                                 Lipid transport (29.4%), sterol transport (23.5%), cholesterol transport (23.5%)                                                                              50         12           0              3.44e−27      57.78
  4                                 Immune system process (54.0%), organ development (68.0%), response to stimulus (74.0%)                                                                        50         13           0              8.58e−29      57.35
  5                                 Response to stimulus (75.0%), response to wounding (40.9%), response to external stimulus (47.7%)                                                             50         7            6              4.60e−14      31.76
  **Unique for Diabetes Samples**                                                                                                                                                                                                                      
  1                                 Response to external stimulus (50.0%), response to wounding (41.3%), cell surface receptor linked signal transduction (58.7%)                                 50         4            0              1.33e−11      51.55
  2                                 Taxis (100.0%), chemotaxis (100.0%), locomotory behavior (100.0%)                                                                                             5          1            0              6.01e−04      40.77
  **Unique for Normal Samples**                                                                                                                                                                                                                        
  1                                 Response to wounding (37.2%), response to stimulus (69.8%), intracellular signaling cascade (51.2%)                                                           50         8            0              1.68e−21      67.49
  2                                 Response to external stimulus (53.8%), response to wounding (46.2%), cell surface receptor linked signal transduction (64.1%)                                 44         5            0              8.36e−13      44.93
  3                                 Cellular di-, tri-valent inorganic cation homeostasis (100.0%), di-, tri-valent inorganic cation homeostasis (100.0%), cellular cation homeostasis (100.0%)   27         2            0              3.28e−06      37.72

The table lists the top related processes, the total number of genes in the network (Size), the number of genes in the network from the input list (Target) and the number of canonical pathways used to build the network (pathways). The comparison of diabetic and non-diabetic samples shows several processes listed under unique to diabetes and unique to normal samples changed in the diabetic and non-diabetic samples.

![Distribution by canonical pathway maps in order of significance and their perturbation in diabetics. This figure shows canonical pathway maps, in order of significance and their perturbation in diabetics. Relevant to diabetes, the immune response and cell adhesion pathways were notably perturbed. Some pathways have been worked out in mouse cells and this is noted. The set of common analytes to both experiments is marked as blue/white stripes. The unique analytes are marked as colored bars (orange=diabetic, blue=normal/non-diabetic).](mv-v15-60-f2){#f2}

![Distribution by GeneGo processes in order of significance and their perturbation in diabetics. This figure shows GeneGo processes in order of significance and their perturbation in diabetics. Relevant to diabetes, the cell adhesion, inflammation and chemotaxis pathways were notably perturbed. The set of common analytes to both experiments is marked as blue/white stripes. The unique analytes are marked as colored bars (orange=diabetic, blue=normal/non-diabetic).](mv-v15-60-f3){#f3}

![Distribution by disease biomarkers in order of significance and their perturbation in diabetics. This figure shows disease biomarkers in order of significance and their perturbation in diabetics. As expected in diabetes, biomarkers for vascular disease, ischemia and infarction showed perturbation. The set of common analytes to both experiments is marked as blue/white stripes. The unique analytes are marked as colored bars (orange=diabetic, blue=normal/non-diabetic).](mv-v15-60-f4){#f4}

Discussion
==========

MAPs are a fully developed and validated technique \[[@r6],[@r7]\]. Rule based medicine\'s (RBM's) MAPs measure markers of cancer, infectious disease, autoimmunity, and cardiovascular risk (similar to age related macular degeneration \[AMD\] risk) as well as hormones, cytokines/chemokines, acute phase reactants, clotting proteins, growth factors, tissue modeling factors, and other typical plasma proteins \[[@r8]\]. A comprehensive analysis of an individual's physiological status can be obtained by measuring a broad spectrum of biomarkers using MAPs. Luminex technology performs up to 100 multiplexed, microsphere-based assays in a single reaction vessel by combining optical classification schemes, biochemical assays, flow cytometry, and advanced digital signal processing hardware and software.

Multiplex analysis has been performed on aqueous samples in the past but with smaller numbers of analytes \[[@r9],[@r10]\]. Our results demonstrate that with this technique around 100 different analytes can be successfully analyzed in small amounts of aqueous samples and provide base line values for 52 analytes. Many of the detected analytes such as CD40, C reactive protein, endothelin, basic fibroblast growth factor (bFGF), fibrinogen, glutathione S-transferase, matrix metalloproteinase (MMP)-3, tissue inhibitors of metalloproteinases (TIMP)-1, and vascular endothelial growth factor (VEGF) are implicated in several ocular pathologies, and therefore, their measurement could provide useful information \[[@r11]-[@r14]\]. Degradation of extracellular matrix proteins is regulated by MMPs. The activity of MMPs is in turn regulated by their natural inhibitors, TIMPs. MMPs and TIMPs play an important role in the pathogenesis of neovascularization in the retina. It is suggested that an imbalance between MMPs and TIMPs leads to neovascularization by affecting levels of VEGF, one of several genes associated with angiogenesis \[[@r15],[@r16]\]. The role of VEGF in retinal as well as iris neovascularization is well established, and anti-VEGF therapy is becoming standard in the management of retinal neovascularization.

The MAP that we used was not specifically designed for ocular conditions. However, a specifically designed MAP for investigating ocular disease processes such as response of treatment (e.g., intravitreal injection of bevacizumab or steroids) can provide valuable and relevant information. It can also provide a method for subclassifying/staging diseases based on the pathophysiological processes.

We further analyzed the detected analytes to demonstrate the usefulness of global analysis in identifying cellular, biological, and disease processes to obtain an overall view of ocular physiology. Analytes represented a large number of pathways, albeit only a small number of proteins represented many of these. It should be noted that the MAP we used in this study did not represent all the cellular processes uniformly. Therefore, our data does not indicate if any cellular process is more prevalent in aqueous than another. We also did not make any attempt to compare the extent of any cellular process represented in the MAP with that expressed in the aqueous. The results demonstrate that aqueous analysis can provide useful information about cellular and disease processes. One of the limitations of using Metacore^TM^ or any other similar program is that the output is not specific for ocular diseases. Output of our results included disease processes such as myocardial infarction and cardiovascular diseases. It is because the program outputs any disease processes where the input analytes participate. Therefore, these results should be interpreted in the context of ocular physiology. At a molecular level, aqueous analysis could identify the canonical pathways and the associated gene networks. The MAP used in this study did not include analytes uniformly across all the cellular/disease processes. Therefore, the data cannot be taken as a representation of these processes in physiological/pathological conditions. Nevertheless, our results demonstrate that the functional processes can be studied using this technology. Moreover, application of specific MAPs can be created to suit specific needs.

Another potential use of such an analysis could be comparing two samples for a global view of changes in the functional processes associated with the ocular environment. Such information may be useful in understanding the pathobiology of a disease, assessing progression of a disease, or response to a treatment. The analysis of diabetic samples provided proof of principle for this hypothesis. The aqueous from diabetic patients showed differences in expected and relevant cellular as well as disease processes. Some processes relevant to diabetic retinopathy were found upregulated in diabetic aqueous samples including CD40, C reactive protein, erythropoietin, fatty acid binding protein, FGF basic, fibrinogen, IL-1ra, IL-8, leptin, macrophage-derived chemokine (MDC), MMP-2, and VEGF \[[@r17],[@r18]\]. Equally relevant for diabetic pathophysiology were creatine kinase-MB, glutathione S-transferase, SGOT, and TNF-β, and they were downregulated in the diabetic aqueous samples \[[@r19],[@r20]\]. It should be noted that since only two diabetic samples were used, changes observed in specific analytes may not be conclusive. Larger sample sizes need to be compared to confirm conclusions. However, this study suggests multiplex analysis may be a valuable global screening technique to identify pathways that warrant further investigation.
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